Recursion Pharmaceuticals-a Earnings

Recursion Pharmaceuticals-a’s revenue jumped 687.81% since last year same period to $35.54Mn in the Q4 2025. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 586.72% jump in its revenue since last 3-months.

Recursion Pharmaceuticals-a’s net profit jumped 39.56% since last year same period to $-108.12Mn in the Q4 2025. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 33.36% jump in its net profits since last 3-months.

Recursion Pharmaceuticals-a’s net profit margin jumped 92.33% since last year same period to -304.25% in the Q4 2025. On a quarterly growth basis, Recursion Pharmaceuticals-a has generated 90.3% jump in its net profit margins since last 3-months.

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current quarter stand at -0.31 - a -2.23% fall from last quarter’s estimates.

Recursion Pharmaceuticals-a’s earning per share (EPS) estimates for the current year stand at -0.31.

Recursion Pharmaceuticals-a’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Recursion Pharmaceuticals-a has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.